Stock Rich List
#13744 on the rich list of 14,452 insiders

Wiaczeslaw Smolokowski

10% owner at Acrivon Therapeutics.

$5.4M
in disclosed stock, −$616K (−10.26%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
13744th of 14,452
Companies held
1
Largest holding
ACRV, 100.0% of total
Latest SEC filing
Jun 26, 2023

What the $5.4M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Acrivon Therapeutics ACRV
Common Stock
Directly3,848,632$1.40$5.4M100.0%Form 4, Jun 26, 2023

Share counts are the amounts Wiaczeslaw Smolokowski reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
13741Greg D. Bertrand
EVP, Sysco. Houston, TX
$5.4M−$54K (−0.99%)
13742Stewart Ellis
Director, Hippo Holdings. San Jose, CA
$5.4M−$40K (−0.73%)
13743Anastasis Nikolaou
10% owner, Acrivon Therapeutics
$5.4M−$616K (−10.26%)
13744Wiaczeslaw Smolokowski
10% owner, Acrivon Therapeutics
$5.4M−$616K (−10.26%)
13745Patrick D. Yeramian
Chief Medical Officer, Amylyx Pharmaceuticals. Cambridge, MA
$5.4M−$86K (−1.58%)
13746Seth Gersch
Director, Global Indemnity Group, LLC. Wilmington, DE
$5.4M−$231K (−4.11%)
13747David Lawrence Churchill
CHIEF TECHNOLOGY OFFICER, BETA Technologies. South Burlington, VT
$5.4M−$349K (−6.08%)

Other Acrivon Therapeutics insiders

All ACRV insiders

Questions

How much stock does Wiaczeslaw Smolokowski own?

Wiaczeslaw Smolokowski holds $5,388,085 in listed stock based on SEC filings and current prices, mostly Acrivon Therapeutics (ACRV). That ranks 13744th on the Stock Rich List.

Is this Wiaczeslaw Smolokowski's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

Files jointly with Andreas Hadjimichael, Marcin Czernik, Anastasis Nikolaou.